De novo posttransplant membranous nephropathy after COVID-19 vaccination 9 years after renal transplantation in a patient with polycystic kidney disease
CEN Case Reports · 2024
DOI: 10.1007/s13730-024-00864-4 ↗Kurz gefasst
Fallbericht in der Zeitschrift CEN Case Reports, 2024. Verfasst von Miruzato Fukuda und 20 weiteren Autor:innen. Beteiligte Einrichtung: Nephrology Center, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo, 105-8470, Japan. mirumiru9201@gmail.com. Hauptthemen laut MEDLINE: COVID-19, COVID-19 Vaccines, Glomerulonephritis, Membranous, Kidney Transplantation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
A 63-year-old man with polycystic kidney disease underwent kidney transplantation from his wife. Nine years later, after the first and second doses of the COVID-19 vaccination, he developed proteinuria, hematuria, and elevated C-reactive protein. Kidney biopsy 7 months after the initial appearance of proteinuria showed immunoglobulin (Ig)-G granular stain, predominantly IgG1, and spike formation in the glomerular basement membrane. Electron microscopy revealed mainly subepithelial deposits, which corresponds to membranous nephropathy (MN) stage 3 of the Ehrenreich-Churg classification indicating chronic disease, but it also showed electron-dense deposits and endothelial damage. Because a kidney biopsy was performed 1 h after renal transplantation and a biopsy of the patient's native kidney showed intact glomeruli, atypical de novo posttransplant membranous nephropathy (MN) was diagnosed, and a close relationship with COVID-19 vaccination was assumed. Clinicians should consider the involvement of COVID-19 vaccination in de novo posttransplant MN with unclear pathogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nephrology Center, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo, 105-8470, Japan. mirumiru9201@gmail.com.
- Okinaka Memorial Institute for Medical Research, Toranomon Hospital, Tokyo, Japan. mirumiru9201@gmail.com.
- Nephrology Center, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo, 105-8470, Japan.
- Okinaka Memorial Institute for Medical Research, Toranomon Hospital, Tokyo, Japan.
- Department of Pathology, Toranomon Hospital, Tokyo, Japan.
- Department of Human Pathology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.
ORCID-Profile: Miruzato Fukuda
Zitieren
APA
Fukuda, M., Yokoyama, T., Miki, K., Yamanouchi, M., Ikuma, D., Mizuno, H., Oba, Y., Inoue, N., Sekine, A., Tanaka, K., Hasegawa, E., Suwabe, T., Wada, T., Kono, K., Kinowaki, K., Ohashi, K., Yamaguchi, Y., Nakamura, Y., Ishii, Y., …, & Ubara, Y. (2024). De novo posttransplant membranous nephropathy after COVID-19 vaccination 9 years after renal transplantation in a patient with polycystic kidney disease. CEN Case Reports. https://doi.org/10.1007/s13730-024-00864-4
Vancouver
Fukuda M, Yokoyama T, Miki K, Yamanouchi M, Ikuma D, Mizuno H, et al. De novo posttransplant membranous nephropathy after COVID-19 vaccination 9 years after renal transplantation in a patient with polycystic kidney disease. CEN Case Reports. 2024. doi:10.1007/s13730-024-00864-4
BibTeX
@article{Fukuda2024,
author = {Fukuda, Miruzato and Yokoyama, Takayoshi and Miki, Katsuyuki and Yamanouchi, Masayuki and Ikuma, Daisuke and Mizuno, Hiroki and Oba, Yuki and Inoue, Noriko and Sekine, Akinari and Tanaka, Kiho and Hasegawa, Eiko and Suwabe, Tatsuya and Wada, Takehiko and Kono, Kei and Kinowaki, Keiichi and Ohashi, Kenichi and Yamaguchi, Yutaka and Nakamura, Yuki and Ishii, Yasuo and Sawa, Naoki and Ubara, Yoshifumi},
title = {De novo posttransplant membranous nephropathy after COVID-19 vaccination 9 years after renal transplantation in a patient with polycystic kidney disease},
journal = {CEN Case Reports},
year = {2024},
doi = {10.1007/s13730-024-00864-4}
}
EUVIMED